Welcome to our dedicated page for Hercules Capital news (Ticker: HTGC), a resource for investors and traders seeking the latest updates and insights on Hercules Capital stock.
Hercules Capital, Inc. provides senior secured venture growth loans to high-growth, venture capital-backed and institutional-backed companies, with an emphasis on technology and life sciences industries. Its updates commonly address debt and equity commitments, loan fundings, portfolio-company financings, net investment income, net asset value, leverage, available liquidity and recurring cash distributions.
Hercules also reports developments involving credit ratings, annual meeting and proxy matters, executive leadership, and its asset management activity through Hercules Adviser LLC and related Adviser Funds. The company’s common stock trades on the NYSE under HTGC, and its retail notes trade under HCXY.
Hercules Capital announced executive leadership changes effective May 18, 2026: Seth Meyer, CFO since 2019, is promoted to President, and Andrew Olson is named Chief Financial Officer and Head of Corporate Development. Meyer will focus on scaling the platform; Olson returns with 19+ years in private credit, alternative asset finance, and prior Hercules experience.
Hercules Capital (NYSE: HTGC) declared a $0.47 per share total cash distribution for Q1 2026, comprising a $0.40 base and $0.07 supplemental distribution.
The record date is May 14, 2026 and the payment date is May 21, 2026. Hercules reported that 100% of Q1 distributions were from current and accumulated earnings and profits, and 78.54% of the distribution qualifies as Qualified Interest Income for U.S. withholding purposes for non-U.S. shareholders.
Hercules Capital (NYSE: HTGC) will release its first quarter 2026 financial results after market close on Tuesday, May 5, 2026, and will host a conference call the same day at 2:00 p.m. PT / 5:00 p.m. ET.
Investors can join via telephone or live webcast on the Investor Resources section of the company's website; archived replay will be available online.
Hercules Capital (NYSE: HTGC) reported an all-time record of $1.81 billion in new debt and equity commitments for Q1 2026. The company originated commitments to 16 new and 12 existing portfolio companies, and expanded financings for several existing holdings.
Management said the firm’s scale, balance sheet and liquidity position it to pursue originations during 2026 market volatility.
enGene (Nasdaq: ENGN) reported Q1 2026 results and provided a development update for detalimogene voraplasmid. Key highlights: $312.5 million cash and marketable securities providing runway into 2H 2028, expanded $125 million Hercules debt facility, and $140.1 million net proceeds from a Nov 2025 offering.
LEGEND pivotal cohort showed promising efficacy (63% CR any time; 56% CR at 3 months; 62% CR at 6 months). enGene plans a BLA submission and expects 12-month data and a conference update in 2026.
Hercules Capital (NYSE: HCXY) announced that Morningstar DBRS affirmed its BBB (high) investment grade corporate and credit rating with a Stable trend on March 4, 2026. DBRS cited the company’s franchise strength, resilient earnings, sound asset credit performance, funding depth and disciplined leverage.
DBRS placed Hercules at the top end of its business development company peer-range and noted the company is positioned to weather volatility from moderating growth and AI-related sentiment, while its software originations focus on firms with domain expertise and higher switching costs.
Hercules Capital (NYSE:HCXY) was named 2025 BDC Manager of the Year - Americas by Private Debt Investor. The award recognizes Hercules’ strong 2025 performance across assets under management, new debt and equity commitments, gross fundings, net debt portfolio growth, and investment income.
Management cited record highs and consistent execution amid tight capital markets and slower fundraising.
Hercules Capital (NYSE: HTGC) reported record full-year 2025 results, with $3.92 billion of total new debt and equity commitments (+45.7% YoY) and $2.28 billion of total fundings (+25.9% YoY).
Other highlights include record full-year investment income of $532.5 million, net investment income of $341.7 million, Q4 commitments of $1.06 billion (+70.8% YoY), available liquidity of over $1.0 billion, undistributed earnings of $149.9 million (≈$0.82 per ending share), and approximately $5.7 billion of assets under management (+20.5% YoY). The company announced a new supplemental 2026 cash distribution of $0.28 per share.
Hercules Capital (NYSE: HTGC) closed an underwritten public offering of $300.0 million aggregate principal amount of unsecured 5.350% notes due February 10, 2029. The Notes pay interest semiannually and are redeemable at the company’s option at par plus a make-whole premium, if applicable.
The company assigned initial ratings of Baa2 by Moody’s and BBB- by Fitch. Net proceeds will fund investments, repay secured indebtedness and support general corporate purposes. Joint book-running managers included Goldman Sachs, SMBC Nikko and MUFG Securities.
Hercules Capital (HCXY) declared a new supplemental cash distribution totaling $0.28 per share, to be paid equally over four quarters beginning with $0.07 per share for Q4 2025. That Q4 supplemental payment has a record date Feb 25, 2026 and payment date March 4, 2026.
The $0.07 supplemental is in addition to the regular Q4 2025 quarterly distribution of $0.40 per share and will be paid from undistributed taxable income as of December 31, 2025. The company reports 78.54% Qualified Interest Income (QII) for 2025 distributions.